Hirotoshi Kataoka Selected Research

Hirotoshi Kataoka Research Topics

3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 12/2005
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2015 - 12/2005
1	Colitis 01/2019
1	Lupus Nephritis 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Sclerosis 01/2019
1	Bradycardia 01/2017
1	Multiple Sclerosis 08/2015
1	Arthritis (Polyarthritis) 12/2013
1	Experimental Arthritis 12/2013
1	Rheumatoid Arthritis 12/2013
1	Demyelinating Diseases (Demyelinating Disease) 12/2005
1	Inflammation (Inflammations) 12/2005
1	Experimental Melanoma 10/2003
1	Melanoma (Melanoma, Malignant) 10/2003
1	Neoplasm Metastasis (Metastasis) 10/2003
1	Neoplasms (Cancer) 10/2003
1	Body Weight (Weight, Body) 10/2003

5	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 12/2005
4	Therapeutic UsesIBA 01/2019 - 12/2005
4	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019 - 03/2011
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017 - 12/2005
3	amiselimodIBA 01/2019 - 01/2017
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	Messenger RNA (mRNA)IBA 12/2013
1	InterleukinsIBA 12/2013
1	CytokinesIBA 12/2013
1	Interleukin-15 (Interleukin 15)IBA 12/2013
1	Interleukin-17 (Interleukin 17)IBA 12/2013
1	Collagen Type II (Type II Collagen)IBA 12/2013
1	InterferonsIBA 03/2011
1	AntigensIBA 12/2005
1	Interferon-betaIBA 12/2005
1	Antineoplastic Agents (Antineoplastics)IBA 10/2003
1	matrigelIBA 10/2003
1	Y 32885IBA 10/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2003
1	Protein Kinases (Protein Kinase)IBA 10/2003

2	Oral Administration 12/2013 - 10/2003
1	Subcutaneous Injections 10/2003